VanEck Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $168M | Sell |
1,204,597
-55,049
| -4% | -$7.71M | 0.13% | 147 |
|
|
2025
Q4 | $155M | Buy |
1,259,646
+624
| +0% | +$75.8K | 0.13% | 143 |
|
|
2025
Q3 | $140M | Sell |
1,259,022
-4,961
| -0.4% | -$564K | 0.13% | 141 |
|
|
2025
Q2 | $140M | Sell |
1,263,983
-2,131,792
| -63% | -$227M | 0.16% | 122 |
|
|
2025
Q1 | $380M | Sell |
3,395,775
-2,727,494
| -45% | -$281M | 0.49% | 49 |
|
|
2024
Q4 | $566M | Sell |
6,123,269
-219,562
| -3% | -$19.8M | 0.72% | 30 |
|
|
2024
Q3 | $553M | Buy |
6,342,831
+22,847
| +0.4% | +$1.74M | 0.69% | 32 |
|
|
2024
Q2 | $434M | Buy |
6,319,984
+747,831
| +13% | +$49.9M | 0.62% | 34 |
|
|
2024
Q1 | $408M | Buy |
5,572,153
+579,738
| +12% | +$44.6M | 0.62% | 45 |
|
|
2023
Q4 | $404M | Buy |
4,992,415
+457,576
| +10% | +$35.6M | 0.74% | 35 |
|
|
2023
Q3 | $340M | Buy |
4,534,839
+702,342
| +18% | +$54M | 0.75% | 29 |
|
|
2023
Q2 | $295M | Buy |
3,832,497
+1,832,292
| +92% | +$146M | 0.65% | 34 |
|
|
2023
Q1 | $166M | Buy |
2,000,205
+18,287
| +0.9% | +$1.51M | 0.38% | 77 |
|
|
2022
Q4 | $170M | Sell |
1,981,918
-1,681,089
| -46% | -$133M | 0.44% | 62 |
|
|
2022
Q3 | $226M | Sell |
3,663,007
-206,643
| -5% | -$13M | 0.67% | 35 |
|
|
2022
Q2 | $239M | Buy |
3,869,650
+311,736
| +9% | +$19.3M | 0.63% | 35 |
|
|
2022
Q1 | $212M | Buy |
3,557,914
+236,611
| +7% | +$15.1M | 0.44% | 53 |
|
|
2021
Q4 | $241M | Buy |
3,321,303
+149,594
| +5% | +$10.3M | 0.56% | 43 |
|
|
2021
Q3 | $222M | Buy |
3,171,709
+208,266
| +7% | +$14.6M | 0.56% | 40 |
|
|
2021
Q2 | $204M | Buy |
2,963,443
+403,756
| +16% | +$27M | 0.48% | 44 |
|
|
2021
Q1 | $165M | Buy |
2,559,687
+342,846
| +15% | +$22.1M | 0.45% | 48 |
|
|
2020
Q4 | $129M | Buy |
2,216,841
+332,288
| +18% | +$20.1M | 0.38% | 55 |
|
|
2020
Q3 | $119M | Buy |
1,884,553
+125,630
| +7% | +$8.71M | 0.38% | 50 |
|
|
2020
Q2 | $135M | Buy |
1,758,923
+182,106
| +12% | +$14M | 0.47% | 33 |
|
|
2020
Q1 | $118M | Sell |
1,576,817
-138,704
| -8% | -$9.58M | 0.6% | 24 |
|
|
2019
Q4 | $111M | Buy |
1,715,521
+304,836
| +22% | +$19.9M | 0.43% | 40 |
|
|
2019
Q3 | $89.4M | Buy |
1,410,685
+9,855
| +0.7% | +$644K | 0.42% | 38 |
|
|
2019
Q2 | $94.6M | Buy |
1,400,830
+103,768
| +8% | +$6.83M | 0.46% | 39 |
|
|
2019
Q1 | $84.3M | Buy |
1,297,062
+218,854
| +20% | +$14.5M | 0.41% | 46 |
|
|
2018
Q4 | $67.4M | Buy |
1,078,208
+50,893
| +5% | +$3.56M | 0.34% | 53 |
|
|
2018
Q3 | $79.3M | Buy |
1,027,315
+217,516
| +27% | +$16.4M | 0.39% | 57 |
|
|
2018
Q2 | $57.4M | Sell |
809,799
-29,167
| -3% | -$2.06M | 0.27% | 85 |
|
|
2018
Q1 | $63.3M | Sell |
838,966
-241,163
| -22% | -$19.2M | 0.31% | 74 |
|
|
2017
Q4 | $77.4M | Buy |
1,080,129
+14,399
| +1% | +$1.09M | 0.38% | 64 |
|
|
2017
Q3 | $86.3M | Sell |
1,065,730
-358,011
| -25% | -$27.4M | 0.44% | 55 |
|
|
2017
Q2 | $101M | Buy |
1,423,741
+12,134
| +0.9% | +$807K | 0.55% | 46 |
|
|
2017
Q1 | $95.9M | Buy |
1,411,607
+201,992
| +17% | +$14.2M | 0.42% | 61 |
|
|
2016
Q4 | $86.6M | Buy |
1,209,615
+97,402
| +9% | +$7.24M | 0.43% | 62 |
|
|
2016
Q3 | $88M | Buy |
1,112,213
+47,722
| +4% | +$3.88M | 0.41% | 63 |
|
|
2016
Q2 | $88.8M | Sell |
1,064,491
-77,280
| -7% | -$6.86M | 0.46% | 53 |
|
|
2016
Q1 | $105M | Buy |
1,141,771
+234,244
| +26% | +$21.1M | 0.71% | 41 |
|
|
2015
Q4 | $91.8M | Sell |
907,527
-159,651
| -15% | -$16.6M | 0.73% | 37 |
|
|
2015
Q3 | $105M | Sell |
1,067,178
-16,122
| -1% | -$1.79M | 0.81% | 33 |
|
|
2015
Q2 | $127M | Sell |
1,083,300
-457,634
| -30% | -$50M | 0.75% | 37 |
|
|
2015
Q1 | $151M | Buy |
1,540,934
+654,743
| +74% | +$66.5M | 0.87% | 32 |
|
|
2014
Q4 | $83.5M | Buy |
886,191
+91,746
| +12% | +$9.49M | 0.52% | 54 |
|
|
2014
Q3 | $84.6M | Sell |
794,445
-88,899
| -10% | -$8.7M | 0.45% | 54 |
|
|
2014
Q2 | $73.2M | Sell |
883,344
-94,115
| -10% | -$7.33M | 0.34% | 69 |
|
|
2014
Q1 | $69.3M | Buy |
977,459
+33,151
| +4% | +$2.6M | 0.34% | 65 |
|
|
2013
Q4 | $70.9M | Buy |
944,308
+61,925
| +7% | +$4.31M | 0.36% | 66 |
|
|
2013
Q3 | $55.5M | Buy |
882,383
+267,114
| +43% | +$16M | 0.28% | 74 |
|
|
2013
Q2 | $31.5M | Buy |
+615,269
| New | +$32.1M | 0.17% | 91 |
|
Other funds holding GILD
VCM
VPM
VanEck Associates's GILD Position: Q1 2026 in Review
VanEck Associates reduced its Gilead Sciences (GILD) stake by 4.4% in Q1 2026, selling an estimated $7.71M and leaving 1,204,597 shares worth $168M. The position accounts for 0.13% of the portfolio, ranked #147.
VanEck Associates first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $566M in Q4 2024. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- VanEck Associates held 1,204,597 shares of Gilead Sciences worth $168M as of Q1 2026.
- VanEck Associates sold 55,049 Gilead Sciences shares in Q1 2026, an estimated $7.71M.
- Gilead Sciences made up 0.13% of VanEck Associates's portfolio in Q1 2026, its #147 holding.
- VanEck Associates first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- VanEck Associates's Gilead Sciences position peaked at $566M in Q4 2024.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.